Reverse Mergers and SPACs: Are APOs the New Norm for Biotechs Going Public?
Cybersecurity Best Practices for 2021
Practical Application of Artificial Intelligence in Drug Discovery and Development
The Seven Habits of Highly Effective Data Rooms
Valuation of Your Early Drug Candidate
Preparing Your Company for the M&A Process
The Art & Science of High M&A Valuation
A Medical Device Manufacturer's Guide to Selecting Suppliers
This white paper covers when to consider using suppliers, key differences between standard / OTS and custom part suppliers, tools and methods for managing suppliers, and when and how to transition between suppliers and internal resources.
Getting Ready for a Biopharma Partnering Deal
How to Apply the Golden Rule of Research to your Trial Master File
This whitepaper evaluates the regulations that support GDP, best practices on how document contributors can apply the golden rule of research to their TMF, how to avoid writing too many and unnecessary Note-to-Files (NTFs), and tips on becoming inspection ready and staying that way.
Must-Know Finance Concepts for Life Sciences Valuations - Part II
This whitepaper discusses which asset valuation methodology is most used by big pharma to evaluate possible partners or acquisitions and an explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital, and present value.